Endocrine Abstracts

Background: CGM based monitoring can help in development of personalized digital therapeutics programs based on the understanding of the effect of diet, physical activity and medications on everyday blood glucose excursions. The variation in intra-individual glycemic response to the same food has been reported in many studies. Thus, understanding of personalized glycemic response (PGR) of each individual becomes important for effective diabetes management.<p class="abstext...

Background: People with chronic metabolic conditions such as type 2 diabetes (T2D) encounter challenges with self-management regimens to improve their glycemic control, weight and as well as to reduce complications associated with diabetes. Optimal management of T2D requires regular monitoring by physician, access to multidisciplinary care and achieving target HbA1c without hypoglycemia. Digital therapeutics (DTx) provide highly accessible, cost-effective, evidence-based solut...

Background and aim: Early glycemic control and weight reduction in diabetes has been associated with prevention of progression of β-cell dysfunction and reduction in diabetes-related complications. Digital therapeutics (DTx) platforms can provide evidence-based therapeutic interventions to improve glycemic control using sustainable behavior change. This study aims at assessing the real-world effectiveness of the Fitterfly Diabetes program in improving glycemic control and...

Background: Managing the relentless requirements of diabetes management can lead to an increase in distress among people with diabetes. There is a need for feasibility studies to understand the effectiveness of multi-disciplinary care delivered using digital therapeutics interventions to provide effective glycemic control along with improved overall well-being of individuals. The study aims to evaluate the feasibility and effectiveness of the Fitterfly diabetes program to impr...